Merit Medical Systems Inc (Merit Medical) designs, develops, manufactures and markets various medical equipment products. It focuses on therapy areas related to interventional, diagnostic and therapeutic procedures primarily in cardiology, radiology, oncology, critical care and endoscopy. The company’s products also find application in other clinical areas including pain management; interventional nephrology; and thoracic, general and vascular surgery. Merit Medical’s major clients include hospitals and clinical cardiologists, radiologists, neurologists, nephrologists, vascular surgeons, interventional gastroenterologists and pulmonologists, thoracic surgeons, physiatrists, technicians, and nurses. The company operates its business through two reportable segments: Cardiovascular and Endoscopy.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Merit Medical focused on enhancing cross-functional collaboration by aligning its research and development and marketing teams with its sales organization to integrate physician feedback into new product development and project prioritization. This approach aims to deliver solutions that meet clinical needs and improve patient outcomes. In 2025, the company completed projects resulting in new product additions, including the 10FoRe hemostasis valve, Ventrax Delivery System, MAK Gold Mini Access Kits, and Prelude Wave Hydrophilic Sheath Introducer with SnapFix technology. The company also introduced simplified connections to its Centesis and Aspira drainage systems to facilitate compatibility with a broader range of drainage tools. In FY2025, the company spent US$97.3 million on its R&D activities, which as a percentage of revenue stood at 6.4% and grew 11.2% YoY. Merit Medical has R&D facilities in California, Texas, Utah in the US; France; and Ireland. As of December 2025, the company owned approximately 2,200 US and international patents and patent applications and owned approximately 840 US and foreign trademark registrations and trademark applications.